A complete response letter (CRL) from the FDA delays a product's entry to the market by an average of 14 months. Companies that receive the letters take an average of seven months just to respond to them. Imagine how much you could save if you could anticipate the FDA's concerns and address them before the agency issues the complete response letter? Now you can.
In a new development which on first glance resembles a storyline plucked from the pages of Harry Potter, researchers at the U.S. Department of Energy’s Argonne National Laboratory, Illinois, have adopted a system of levitation in order to more effectively develop pharmaceuticals - no magic wand required. gizmag